Raltitrexed‐Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT‐116 Human Cancer Cells

Files in this item

This item appears in the following Collection(s)

Search Repository


Advanced Search

Browse

My Account

Statistics